Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
137
137 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- GFS202APhase 21 trial
Genfleet Therapeutics (Shanghai) Inc. · Pancreatic Cancer
- GI-108Phase 21 trial
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Cancer (NSCLC)
- GTAEXS617REC-617Phase 21 trial
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC)
- HCW9218Phase 21 trial
ImmunityBio, Inc. · Advanced Pancreatic Carcinoma
- HRS-717Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer
- HRS-7172Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer
- HY-0102Phase 21 trial
Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer
- INV-8989Phase 21 trial
Shenzhen Ionova Life Sciences Co., Ltd. · Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC
- IPN01194Phase 21 trial
Ipsen · Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma
- IvaltinostatPhase 21 trial
CG Pharmaceuticals, Inc · Metastatic Pancreatic Adenocarcinoma
- JMT203Phase 21 trial
Shanghai JMT-Bio Inc. · Non Small Cell Lung Cancer, Pancreatic Cancer, Cancer Cachexia
- JYP0015Phase 21 trial
Guangzhou JOYO Pharma Co., Ltd · Solid Tumor, Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC)
- KN713Phase 21 trial
New Cancer Cure-Bio Co.,Ltd. · Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
- LG00313112Phase 21 trial
LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer
- LP-184Phase 21 trial
Lantern Pharma Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, GBM
- LUM015Phase 21 trial
Lumicell, Inc. · Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer
- MR001Phase 21 trial
Shenzhen Majory Biotechnology Co., Ltd. · Pancreatic Ductal Adenocarcinoma (PDAC)
- MT-4561Phase 21 trial
Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer
- narmafotinibPhase 21 trial
Amplia Therapeutics Limited · Pancreatic Cancer Metastatic
- NHS7108Phase 21 trial
Aimmune Nestlé Health Science US R&D, LLC · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality
- NUV-1511Phase 21 trial
Nuvation Bio Inc. · Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC)
- PBP1510Phase 21 trial
Prestige Biopharma Limited · Pancreatic Cancer
- PEGPH20Phase 21 trial
Roche (Genentech) · Pancreatic Adenocarcinoma
- PepinemabPhase 21 trial
Vaccinex Inc. · Metastatic Pancreatic Adenocarcinoma
- RO6874281Phase 21 trial
Roche (Genentech) · Pancreatic Adenocarcinoma
- RP-001Phase 21 trial
Recurv Pharma Inc · Advanced Malignancies, Oncology, Colorectal Cancer
- RR001Phase 21 trial
EIR Biotherapies s.r.l. · Locally Advanced Pancreatic Adenocarcinoma
- SNS-101anti-VISTAPhase 21 trial
Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer
- SYS6062Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Gastric Cancer (GC), Colorectal Cancer (CRC)
- VB15010Phase 21 trial
Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Cancer, Neoplasms, Neoplasms, Breast
- VMD-928Phase 21 trial
VM Oncology, LLC · Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer
- vopimetostatPhase 21 trial
Tango Therapeutics, Inc. · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC
- WEF-001Phase 21 trial
Auricula Biosciences Inc. · Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer
- XER-001Phase 21 trial
Xerient Pharma · Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced Pancreas Cancer, Locally Advanced Pancreatic Ductal Adenocarcinoma
- XYA02Phase 21 trial
XYone Therapeutics, Inc · MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer
- Y101DPhase 21 trial
Wuhan YZY Biopharma Co., Ltd. · Advanced Pancreatic Adenocarcinoma
- YL-13027Phase 21 trial
Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.